Enrolling by Invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
- Locations
-
- Alabama Neurology Associates- Site Number : 8400019 Homewood, Alabama, United States
- University of Kansas Medical Center- Site Number : 8400010 Kansas City, Kansas, United States
- Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022 Philadelphia, Pennsylvania, United States
- Investigational Site Number : 0320003 Buenos Aires, Argentina